{
    "2021-06-11": [
        [
            {
                "time": "",
                "original_text": "药明康德：股东上海瀛翊违反承诺减持公司股份 减持股份",
                "features": {
                    "keywords": [
                        "药明康德",
                        "股东",
                        "上海瀛翊",
                        "违反承诺",
                        "减持"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "江苏区域股市周报：新增1家上市公司 63家机构调研前沿生物-U",
                "features": {
                    "keywords": [
                        "江苏",
                        "股市周报",
                        "新增上市公司",
                        "机构调研",
                        "前沿生物-U"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "对标药明康德和泰格医药，第三方商业化平台百洋医药价值几何",
                "features": {
                    "keywords": [
                        "药明康德",
                        "泰格医药",
                        "百洋医药",
                        "第三方商业化平台"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "康龙化成(300759)：推出股票激励计划保障长期健康发展",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "股票激励计划",
                        "长期健康发展"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "揭秘送转股 132只除权以来股价上涨",
                "features": {
                    "keywords": [
                        "送转股",
                        "除权",
                        "股价上涨"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "百元股数量达163只，一日增加5只",
                "features": {
                    "keywords": [
                        "百元股",
                        "数量增加"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "速递 | 优于二线标准治疗，CAR-T疗法达到3期临床主要终点",
                "features": {
                    "keywords": [
                        "CAR-T疗法",
                        "临床主要终点",
                        "二线标准治疗"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}